Seeking Alpha


Send Message
View as an RSS Feed
Latest  |  Highest rated
  • FDA denies Amarin's ANCHOR SPA appeal [View news story]
    No other company generates more bad news than Amarin. It never ends! But Joe Z continues to give himself pay increases! Amazing!
    Nov 22, 2013. 08:17 AM | 1 Like Like |Link to Comment
  • Amarin (AMRN -0.5%) continues its slide on the back of Friday's news that NCE status on Vascepa was once again delayed. However, MKM Partners analyst Jon LeCroy thinks the delay may have a silver lining. Lecroy says that while the NCE designation is the preferred outcome here, the delay also prevents the company from being targeted for a takeover. The shares are likely to remain under pressure until an NCE decision is made though, which MKM expects to come around July 12. [View news story]
    Would be great if July 12 NCE was based on anything other than pure speculation.
    Jun 18, 2013. 03:21 PM | Likes Like |Link to Comment
  • Shares of Amarin (AMRN -1.1%) rebound somewhat from an earlier dip on news that its Vascepa wasn't in the FDA's Orange Book for April. [View news story]
    Perhaps Amarin should have contributed heavily to Obama's re-election campaign fund. Seems that how things get done under this administration.
    May 18, 2013. 10:07 AM | Likes Like |Link to Comment
  • Today's Non-Move By FDA Tells Us One Thing... [View instapost]
    What are the script numbers reported this week?
    Apr 15, 2013. 10:10 AM | Likes Like |Link to Comment
  • OMTH Proposed IPO Non-Starter [View instapost]
    Steve, I requested info from Amarin regarding whether the 30 day free supply is counted through IMS but as I have discovered they do not respond to shareholder inquiries. My question to you though is this.......The "free" scripts actually are paid scripts....since Amarin does pay for those 30 day "free" scripts how is it you consider them unpaid scripts?
    Mar 26, 2013. 05:03 AM | Likes Like |Link to Comment
1 Like